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Signs and Symptoms 
Acute Immune Thrombocytopenia Purpura 
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Figure 2. Model of relationship of 
contributing factors in ITP.  Adapted  
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Figure 1. Coating of Platelets with 
Autoantibodies.   This figure shows 
the binding of IgG to platelet surface.  
Adapted from “Idiopathic 
thrombocytic purpura”, by D. 
Winkeljohn, 2010, 14(4), p. 411. 
   
       Acute ITP is usually a self-limiting 
disorder that resolves within six 
months, but it can progress to the 
chronic form of the disorder which 
patients may deal with for a lifetime.  
While the exact etiology of ITP is 
unknown, acute ITP is often preceded 
by a viral infection a few days or weeks 
prior to the onset of symptoms.  The 
majority of the time, no pathogen is 
identified but in a small number of 
cases, Epstein-Barr virus, influenza and 
varicella-zoster virus have been 
detected.  ITP is also a known, but very 
rare complication of the measles-
mumps-rubella vaccine (Johnsen, 
2012).  This complication corresponds 
with the concept of antigenic mimicry 
or provocation of the immune system 
resulting in an autoimmune response.  
Patients with one autoimmune disease 
are at a higher risk of developing a 
second autoimmune disease.  ITP has 
been shown to arise in individuals with 
systemic autoimmune diseases such as 
systemic lupus erythematous and 
rheumatoid arthritis (Johnsen, 2012).   
       ITP occurs with varying levels of 
thrombocytopenia.  Patients that 
present without any signs of active 
bleeding and a platelet count greater 
than 10,000/mm³ usually do not 
require treatment (Buchanan, 2014).  
However, patients with platelet counts 
less than 10,000/mm³, active bleeding, 
comorbidities, or any risk for trauma 
will be treated with drug therapies 
(Bredlau, Semple & Segal, 2011).   
 
 
. 
       
       Acute ITP is a complex autoimmune 
disorder characterized by isolated 
thrombocytopenia.  ITP can involve both 
increased platelet destruction and 
decreased platelet production (Kime, 
Klima, Rose & O’Brien, 2013).   ITP 
results from autoantibody 
immunoglobulin G (IgG) binding to 
glycoproteins, typically GPIIb/IIIa, on 
the surface of the platelets (Bredlau, 
Semple, & Segel, 2011).  IgG that is 
bound to circulating platelets serves as 
an opsonin (a molecule that enhances 
phagocytosis by marking an antigen for 
an immune response) and induces 
increased platelet phagocytosis and 
destruction by mononuclear 
macrophages primarily occurring in the 
spleen (Lo & Deane, 2014).  Anti-platelet 
antibodies also combine with the antigen 
to form an immune complex which leads 
to activation of complement, and results 
in phagocytosis and increased lysis of 
platelets (Johnsen, 2012).   
       Acute ITP is often preceded by a viral 
infection which is thought to trigger this 
autoimmune response.  The concept of 
antigenic mimicry may occur in 
response to this viral infection.   The 
antigen on the viral surface may closely 
resemble the antigen on the platelet 
surface leading to the antibodies 
recognizing the platelets as foreign 
resulting in platelet removal by 
phagocytosis (Abadi, Yarchovsky-
Dolberg & Ellis, 2015).  
       Recent research has shown that with 
ITP, there is also a dysfunction of 
megakaryocytes (large cells in the bone 
marrow that break into fragments that 
become platelets).  Megakaryocyte 
production and differentiation is 
stimulated by the hormone 
thrombopoietin.  Thrombopoietin is 
secreted by the liver in response to 
alterations in platelet count, however, 
this response is impaired in patients 
with ITP (Lu & Nossent, 2015).  This 
impaired production of thrombopoietin 
leads to abnormalities in 
megakaryocytes and a decreased 
production of platelets (Labarque & 
Geet, 2014).  The IgG autoantibodies 
may also bind with proteins on the 
membrane of megakaryocytes impairing 
the fragmentation of megakaryocytes 
into platelets and inducing apoptosis 
(Maher, 2014).  
Acute ITP is a disorder that is most 
often managed by specialists in 
hematology.   All nursing professionals 
should have a general understanding of 
the disease process because nurses of all 
levels and specialties may come in 
contact with this disorder at some time.  
Patients are likely to present to their 
primary care provider with the onset of 
signs and symptoms of ITP.  This 
provider should be able to recognize and 
identify the potential for this disorder 
and also have an understanding of the 
potential complications that may arise as 
a result of ITP.   Having this 
understanding is essential to performing 
appropriate testing and making 
recommendations for further 
management including possible referral 
to a specialist.  Although the cause of ITP 
is still under investigation, certain 
infections and vaccinations do precede 
some cases.  Patients diagnosed with 
other autoimmune disorders are also 
more likely to develop ITP throughout 
their lifetime (Johnsen, 2012).  The 
increased risk for bleeding associated 
with ITP can also place patients at a 
much higher risk of developing bleeding 
complications from medical procedures 
(Hunt, 2010).  To implement appropriate 
interventions that can prevent 
complications from these procedures, an 
understanding of ITP is necessary.  
       Immune thrombocytopenic purpura 
(ITP), formerly known as idiopathic 
thrombocytopenic purpura, is a 
relatively rare, but potentially life 
threatening autoimmune disorder that 
involves the destruction of platelets by 
autoantibodies.  The resultant 
decreased platelet count leaves the 
patient at risk for excessive bruising 
and bleeding (Hunt, 2010).  ITP can 
occur in both adults and children, and 
also occurs as an acute or chronic 
disorder.  It is thought that the cause of 
acute ITP may differ from that of 
chronic ITP, however, the underlying 
disease processes that occur are very 
similar (Johnsen, 2012).  Acute ITP, the 
most common form of the disease, most 
often occurs in children (Hunt, 2010).  
It is estimated that acute ITP occurs in 
as many as 6.4 per 100,000 children per 
year (Deane, 2014).  Most children 
diagnosed with acute ITP have a history 
of a recent viral infection, usually 
occurring three to four weeks prior to 
diagnosis.  The majority of cases are 
relatively mild and nearly 50 percent of 
these cases will resolve within two 
months.  The most serious, but very 
rare, complication of ITP is intracranial 
hemorrhage (Maher, 2014).   
       Throughout my experience in 
pediatric hematology/oncology, I have 
cared for a number of patients 
diagnosed with acute ITP.  Although ITP 
is generally treated by specialists in 
hematology, most patients present to 
their primary care practitioner with the 
onset of signs and symptoms.  
Thrombocytopenia can also be seen in 
other hematological and oncological 
diseases and often, ITP is a diagnosis of 
exclusion.  It is important that primary 
care practitioners that treat both adults 
and children recognize the presenting 
symptoms of this disease to begin the 
proper work-up.  Although this disorder 
is rare, it is essential for practitioners to 
be aware of this condition to consider it 
as a potential diagnosis and identify 
patients at risk for severe complications 
of the disease. 
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Nursing Implications 
ITP is an autoimmune disorder in 
which the body attacks its own platelets.  
ITP occurs in both an acute and chronic 
form.   Acute ITP typically occurs in 
otherwise healthy children but can also 
occur in teenagers and adults of all ages.  
Acute ITP is associated with a sudden 
onset of symptoms (Maher, 2014).  This 
disorder is associated with an increased 
risk for bleeding and therefore, increased 
awareness and recognition of this 
disorder is key to avoiding the potential 
complications. 
Conclusion 
Case Study 
       A mother brought her previously healthy two-year-old son to his primary care 
provider with concerns about sudden onset scattered bruising to his bilateral legs, arms 
and trunk, purple freckles to his bilateral upper extremities, and a twenty minute 
nosebleed.  The patient’s mother denied that her son had experienced any pain, fever, 
fatigue, recent weight loss, headache, or recent trauma.  The patient had a positive history 
of upper respiratory infection about three weeks ago per the patient’s mother.  The 
patient's mother reported no relevant past medical history, no current medication use, and 
no family history of bleeding disorders or cancers.   
       On physical exam, the patient was noted to be very active with vital signs within 
normal limits for the patient’s age. Temperature 99.0°F, heart rate 114 beats/minute, 
blood pressure 92/58, respiratory rate 28 breaths/minute, and oxygen saturation of 99% 
on room air.  No pallor was noted, but significant scattered ecchymosis and petechiae were 
present to patient’s trunk and bilateral upper and lower extremities.  The remainder of the 
physical exam was normal, specifically no lymphadenopathy, splenomegaly, or 
hepatomegaly were noted (Labarque & Geet, 2014).  
       A complete blood count (CBC) was obtained and examination of peripheral blood 
smear was performed (Labarque & Geet, 2014).  The patient’s CBC showed a normal white 
blood cell (WBC) count of 6,800/mm³, normal hemoglobin (Hgb) of 13.7g/dl, and a 
decreased platelet count of 17,000/mm³.  The peripheral blood smear appeared normal 
with the exception of an increase in average platelet size (Maher, 2014).   
 
 
 
 
 
ITP is often a diagnosis of exclusion 
and patients can present with no obvious 
symptoms. ITP is generally defined by a 
platelet count of less than 100,000/mm³ 
(Lo & Deane, 2014).    The 
thrombocytopenia can be an incidental 
finding on a routine CBC because signs 
and symptoms associated with ITP may 
not be apparent until the platelets drop 
below 30,000/mm³.   
Acute ITP usually has an abrupt onset 
of symptoms and can occur in otherwise 
healthy individuals (Maher, 2014).  
Common signs of ITP are easy bruising, 
petechiae, prolonged bleeding from cuts 
or scrapes, epistaxis, menorrhagia, and 
mucosal bleeding (Hunt, 2010).  Blood 
may be present in the urine, stool, or 
sputum, but this is much less common 
(Maher, 2014).  Intracranial hemorrhage 
is the most dangerous, but very rare 
complication of ITP.  Individuals with 
intracranial hemorrhage may complain of 
headaches, blurry vision, or display a 
change in or loss of consciousness.  
Individuals that present with mucosal 
bleeding are more likely to experience 
intracranial hemorrhage (Hunt, 2010). 
 
Figure 3.  Petechiae and 
Purpura.  Bleeding under the 
skin causes the red and purple 
discoloration. Cleveland Clinic 
Foundation (2012) Retrieved 
from 
http://my.clevelandclinic.org 
